Basics VYNE Therapeutics Inc. IPO Date: January 22, 2018 Sector: Healthcare Market Cap: $12.32M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 4.18% Avg Daily Range (30 D): $0.01 | 2.95% Avg Daily Range (90 D): $0.01 | 3.67% Institutional Daily Volume Avg Daily Volume: 1M Avg Daily Volume (30 D): 1.18M Avg Daily Volume (90 D): 2.24M Trade Size Avg Trade Size (Sh.): 330 Avg Trade Size (Sh.) (30 D): 653 Avg Trade Size (Sh.) (90 D): 750 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.55M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.91M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 31.93K     News Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight Jun 26, 2024 @ 12:00 PM VYNE Therapeutics to Participate in Leerink Partne... Source: VYNE Therapeutics Inc. Jun 14, 2024 @ 1:01 PM Analyst Scoreboard: 4 Ratings For VYNE Therapeutic... Source: Benzinga Insights Jun 13, 2024 @ 1:02 PM VYNE Therapeutics Announces Dosing of First Partic... Source: VYNE Therapeutics Inc. May 9, 2024 @ 1:15 PM VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Mis... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.91 $-.13 $-.2 Diluted EPS $-.91 $-.13 $-.2 Revenue $ .48M $ .07M $ .2M Gross Profit $ $ $ Net Income / Loss $ -38.55M $ -5.76M $ -8.61M Operating Income / Loss $ -42.6M $ -7.54M $ -9.2M Cost of Revenue $ $ $ Net Cash Flow $ -7.61M $ -6.16M $ 8.28M PE Ratio     Splits Feb 13, 2023:   1:18 Feb 16, 2021:   1:4